Yen-ying Chen
Taipei, TNQ 11217, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Protease-activated anti-Lewis Y antibody enhances selectivity and safety of glycan-targeting cancer therapy.
Journal: International journal of biological macromolecules
Published: February 17, 2025
Pcsk9 Deletion Promotes Murine Nonalcoholic Steatohepatitis and Hepatic Carcinogenesis: Role of Cholesterol.
Journal: Hepatology communications
Published: May 28, 2021
Non-alcoholic fatty liver disease: A review with clinical and pathological correlation.
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: January 08, 2020
Immune-related adverse reactions in the hepatobiliary system: second-generation check-point inhibitors highlight diverse histological changes.
Journal: Histopathology
Published: July 25, 2019
Radiological features and outcomes of combined hepatocellular-cholangiocarcinoma in patients undergoing surgical resection.
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: December 05, 2018
Upregulation of miR-125b, miR-181d, and miR-221 Predicts Poor Prognosis in MGMT Promoter-Unmethylated Glioblastoma Patients.
Journal: American journal of clinical pathology
Published: March 15, 2018
Loss of BCAT1 Expression is a Sensitive Marker for IDH-Mutant Diffuse Glioma.
Journal: Neurosurgery
Published: January 30, 2018
Advancing a High Throughput Glycotope-centric Glycomics Workflow Based on nanoLC-MS2-product Dependent-MS3 Analysis of Permethylated Glycans.
Journal: Molecular & cellular proteomics : MCP
Published: June 26, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026